Chapter 48. Management of Hepatocellular Cancer

  1. Howard Thomas BSc PhD FRCP FRCpath FMedSci Professor1,
  2. Stanley Lemon Professor2 and
  3. Arie Zuckerman MD, DSc, FRCP, FRCPath, FMedSci, Dip. Bact Professor3
  1. Helen L Reeves and
  2. Jordi Bruix

Published Online: 26 OCT 2007

DOI: 10.1002/9780470987131.ch48

Viral Hepatitis, Third Edition

Viral Hepatitis, Third Edition

How to Cite

Reeves, H. L. and Bruix, J. (2005) Management of Hepatocellular Cancer, in Viral Hepatitis, Third Edition (eds H. Thomas, S. Lemon and A. Zuckerman), Blackwell Publishing Ltd, Oxford, UK. doi: 10.1002/9780470987131.ch48

Editor Information

  1. 1

    Dean (Clinical) Faculty of Medicine, Imperial College, Department of Medicine, Queen Elizabeth Queen Mother Wing, St Mary's Hospital Medical School, London UK

  2. 2

    Dean of Medicine, Department of Microbiology & Immunology & Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA

  3. 3

    The Royal Free Hospital of Medicine, Rowland Hill Street, London, UK

Publication History

  1. Published Online: 26 OCT 2007
  2. Published Print: 12 JUL 2005

ISBN Information

Print ISBN: 9781405130059

Online ISBN: 9780470987131

SEARCH

Keywords:

  • hepatocellular cancer;
  • staging systems;
  • barcelona-clínic-liver-cancer (BCLC) staging system;
  • vascular invasion;
  • proteomic characterization

Summary

This chapter contains sections titled:

  • Background

  • Risk factors and prevention of disease

  • Surveillance and recall of high-risk individuals

  • Staging systems in HCC

  • Treatment

  • The future

  • Conclusion